Evidence map›Paper›PMID 24293574›Full record

ArticleThe Journal of rheumatology2014

Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.

Miwa Uzuki, Takashi Sawai, Lawrence M Ryan, Ann K Rosenthal, Ikuko Masuda

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of rheumatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. BONE MARKERS IN ARTHROPATHIES.Acta clinica Croatica · 2019
    Review
  6. Calcium crystal deposition diseases - beyond gout.Nature reviews. Rheumatology · 2018
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Miwa UzukiFrom the Department of Pathology, Division of Leading Pathophysiology, Iwate Medical University, School of Medicine, Iwate, Japan; Division of Rheumatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
Takashi Sawai
Lawrence M Ryan
Ann K Rosenthal
Ikuko Masuda
Tokyo Women's Medical University · JPIwate Medical University · JPMedical College of Wisconsin · US

Funding

Modifiable Disparities in Treatment for Rheumatoid ArthritisR01AR056215 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SOLOMON, DANIEL HAL · 2009 to 2012
$1.9M
INORGANIC PYROPHOSPHATE METABOLISM IN ARTHRITISR01AR038656 · NIAMS · MEDICAL COLLEGE OF WISCONSIN · PI RYAN, LAWRENCE M. · 1987 to 2006
$1.4M
Matrix proteins promote matrix vesicle mineralizationR01AR052615 · NIAMS · MEDICAL COLLEGE OF WISCONSIN · PI ROSENTHAL, ANN K · 2005 to 2007
$480k
ANK-dependent ATP efflux causes calcium pyrophosphate deposition in cartilageI01CX001143 · VA · CLEMENT J. ZABLOCKI VA MEDICAL CENTER · PI ROSENTHAL, ANN K · 2015 to 2018
–
CSRD VA I01 CX001143NIAMS NIH HHS AR-38656NIAMS NIH HHS AR-44682NIAMS NIH HHS R01 AR052615NIAMS NIH HHS R01-AR-056215
6 · The paper itself

Abstract

objectiveAccumulation of excess extracellular inorganic pyrophosphate leads to calcium pyrophosphate dihydrate (CPPD) crystal formation in articular cartilage. CPPD crystal formation occurs near morphologically abnormal chondrocytes resembling hypertrophic chondrocytes. The ANK protein was recently implicated as an important factor in the transport of intracellular inorganic pyrophosphate across the cell membrane. We characterized ANK in joint tissues from patients with and without CPPD deposition and correlated the presence of ANK with markers of chondrocyte hypertrophy.

methodsArticular tissues were obtained from 24 patients with CPPD crystal deposition disease, 11 patients with osteoarthritis (OA) without crystals, and 6 controls. We determined the number of ANK-positive cells in joint tissues using immunohistochemistry and in situ hybridization, and correlated ANK positivity with markers of chondrocyte hypertrophy including Runx2, type X collagen, osteopontin (OPN), and osteocalcin (OCN).

resultsANK was detected in synoviocytes, chondrocytes, osteoblasts, and osteocytes. ANK was seen extracellularly only in the matrix of cartilage and meniscus. The number of ANK-positive cells was significantly higher in CPPD than in OA or normal joint tissues. The amount and intensity of ANK immunoreactivity reached maximum levels in the large chondrocytes around crystal deposits. ANK was similarly distributed to and significantly correlated with Runx2, type X collagen, OPN, and OCN.

conclusionANK levels were higher in articular tissues from patients with CPPD deposition. ANK was concentrated around crystal deposits and correlated with markers of chondrocyte hypertrophy. These findings support a role for ANK in CPPD crystal formation in cartilage.

Indexed as

Up-RegulationAdultAgedBone and BonesCartilage, ArticularChondrocalcinosisChondrocytesFemaleHumansJointsMaleMiddle AgedOsteoarthritisPhosphate Transport ProteinsANKH protein, humanPhosphate Transport ProteinsANKCALCIUM PYROPHOSPHATE DIHYDRATECARTILAGEIMMUNOHISTOCHEMISTRYIN SITU HYBRIDIZATIONPATHOLOGY

Identifiers

PMID24293574
PMCPMC6240442
OpenAlexW2045224218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.